These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 36810544)

  • 1. Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response.
    Ajmal MR
    Diseases; 2023 Feb; 11(1):. PubMed ID: 36810544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation.
    Ahanger IA; Ashraf GM; Sharma A; Islam A
    CNS Neurol Disord Drug Targets; 2024; 23(2):153-180. PubMed ID: 36876837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Quality Control by Molecular Chaperones in Neurodegeneration.
    Ciechanover A; Kwon YT
    Front Neurosci; 2017; 11():185. PubMed ID: 28428740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
    Hervás R; Oroz J
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.
    Naiki H; Nagai Y
    J Biochem; 2009 Dec; 146(6):751-6. PubMed ID: 19643812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct role of hydration water in protein misfolding and aggregation revealed by fluctuating thermodynamics analysis.
    Chong SH; Ham S
    Acc Chem Res; 2015 Apr; 48(4):956-65. PubMed ID: 25844814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein misfolding and aggregation by natural phenolic compounds.
    Dhouafli Z; Cuanalo-Contreras K; Hayouni EA; Mays CE; Soto C; Moreno-Gonzalez I
    Cell Mol Life Sci; 2018 Oct; 75(19):3521-3538. PubMed ID: 30030591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome.
    Huiting W; Dekker SL; van der Lienden JCJ; Mergener R; Musskopf MK; Furtado GV; Gerrits E; Coit D; Oghbaie M; Di Stefano LH; Schepers H; van Waarde-Verhagen MAWH; Couzijn S; Barazzuol L; LaCava J; Kampinga HH; Bergink S
    Elife; 2022 Feb; 11():. PubMed ID: 35200138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
    Furkan M; Khan RH
    Curr Protein Pept Sci; 2020; 21(6):573-583. PubMed ID: 32013844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation.
    Kushwah N; Jain V; Yadav D
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31941036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress and molecular chaperones in disease.
    Macario AJ; Conway de Macario E
    Int J Clin Lab Res; 2000; 30(2):49-66. PubMed ID: 11043498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing the Multistep Process of Protein Aggregation in Live Cells.
    Ye S; Hsiung CH; Tang Y; Zhang X
    Acc Chem Res; 2022 Feb; 55(3):381-390. PubMed ID: 35040316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native State Stabilization of Amyloidogenic Proteins by Kinetic Stabilizers: Inhibition of Protein Aggregation and Clinical Relevance.
    Priyanka ; Raymandal B; Mondal S
    ChemMedChem; 2024 Oct; 19(19):e202400244. PubMed ID: 38863235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of molecular chaperone in protein-misfolding brain diseases.
    Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
    Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Insight into the Protein Aggregation in Alzheimer's Disease and its Inhibition.
    Khan AB; Khan RH
    Protein Pept Lett; 2023; 30(11):900-912. PubMed ID: 37953619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease.
    Webster JM; Darling AL; Uversky VN; Blair LJ
    Front Pharmacol; 2019; 10():1047. PubMed ID: 31619995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.